Kim Francis, Olsufka Michele, Longstreth W T, Maynard Charles, Carlbom David, Deem Steven, Kudenchuk Peter, Copass Michael K, Cobb Leonard A
Department of Medicine, Box 359748, Harborview Medical Center, University of Washington, Seattle, WA 98104, USA.
Circulation. 2007 Jun 19;115(24):3064-70. doi: 10.1161/CIRCULATIONAHA.106.655480. Epub 2007 Jun 4.
Although delayed hospital cooling has been demonstrated to improve outcome after cardiac arrest, in-field cooling started immediately after the return of spontaneous circulation may be more beneficial. The aims of the present pilot study were to assess the feasibility, safety, and effectiveness of in-field cooling.
We determined the effect on esophageal temperature, before hospital arrival, of infusing up to 2 L of 4 degrees C normal saline as soon as possible after resuscitation from out-of-hospital cardiac arrest. A total of 125 such patients were randomized to receive standard care with or without intravenous cooling. Of the 63 patients randomized to cooling, 49 (78%) received an infusion of 500 to 2000 mL of 4 degrees C normal saline before hospital arrival. These 63 patients experienced a mean temperature decrease of 1.24+/-1 degrees C with a hospital arrival temperature of 34.7 degrees C, whereas the 62 patients not randomized to cooling experienced a mean temperature increase of 0.10+/-0.94 degrees C (P<0.0001) with a hospital arrival temperature of 35.7 degrees C. In-field cooling was not associated with adverse consequences in terms of blood pressure, heart rate, arterial oxygenation, evidence for pulmonary edema on initial chest x-ray, or rearrest. Secondary end points of awakening and discharged alive from hospital trended toward improvement in ventricular fibrillation patients randomized to in-field cooling.
These pilot data suggest that infusion of up to 2 L of 4 degrees C normal saline in the field is feasible, safe, and effective in lowering temperature. We propose that the effect of this cooling method on neurological outcome after cardiac arrest be studied in larger numbers of patients, especially those whose initial rhythm is ventricular fibrillation.
尽管延迟医院降温已被证明可改善心脏骤停后的预后,但自主循环恢复后立即开始的现场降温可能更有益。本初步研究的目的是评估现场降温的可行性、安全性和有效性。
我们确定了院外心脏骤停复苏后尽快输注多达2升4℃生理盐水对入院前食管温度的影响。共有125例此类患者被随机分为接受标准治疗(有无静脉降温)两组。在随机分组接受降温的63例患者中,49例(78%)在入院前接受了500至2000毫升4℃生理盐水的输注。这63例患者的平均体温下降了1.24±1℃,入院时体温为34.7℃,而未随机分组接受降温的62例患者平均体温升高了0.10±0.94℃(P<0.0001),入院时体温为35.7℃。现场降温在血压、心率、动脉氧合、初始胸部X线片上有无肺水肿证据或再次心脏骤停方面均未产生不良后果。对于随机分组接受现场降温的室颤患者,次要终点清醒和出院存活情况有改善趋势。
这些初步数据表明,在现场输注多达2升4℃生理盐水来降低体温是可行、安全且有效的。我们建议在更多患者中研究这种降温方法对心脏骤停后神经功能结局的影响,尤其是那些初始心律为室颤的患者。